Literature DB >> 3090749

Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity.

Z Brown, G H Neild, J J Willoughby, N V Somia, S J Cameron.   

Abstract

Very high plasma concentrations of factor-VIII-related antigen (RAG) (VIII-RAG) were found in renal allograft recipients during periods of nephrotoxicity induced by cyclosporine. In eight recipients, who were investigated at weekly intervals, levels of factor-VIII-RAG fell toward normal as the dose of cyclosporine was reduced. Plasma levels of C-reactive protein, an acute phase reactant protein, were never raised in these recipients. These findings are further evidence that toxic doses of cyclosporine are associated with vascular injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090749     DOI: 10.1097/00007890-198608000-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Glomerular vasculopathy after unrelated cord blood transplantation.

Authors:  Chihaya Imai; Toshio Kakihara; Haruko Iwabuchi; Atsushi Tanaka; Tatsuo Furukawa; Makoto Uchiyama
Journal:  Pediatr Nephrol       Date:  2003-03-21       Impact factor: 3.714

2.  Recurrent haemolytic uraemic syndrome in a boy with focal and segmental glomerulosclerosis.

Authors:  A Bökenkamp; P F Hoyer; G Offner; U Helmchen; J Brodehl
Journal:  Eur J Pediatr       Date:  1992-10       Impact factor: 3.183

Review 3.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 4.  Heart transplantation: cellular and humoral immunity.

Authors:  M L Rose; M H Yacoub
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells.

Authors:  T E Bunchman; C A Brookshire
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis.

Authors:  G Frampton; D R Jayne; G J Perry; C M Lockwood; J S Cameron
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 7.  Clinical use of cyclosporin in rheumatoid arthritis.

Authors:  C Richardson; P Emery
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 8.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

9.  Cyclosporine-induced nephrotoxicity in deoxycorticosterone-NaCl treated rats.

Authors:  J M Wyss; M S Mozaffari; P L St John; D R Abrahamson
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

10.  Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit.

Authors:  H S Cairns; L D Fairbanks; J Westwick; G H Neild
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.